Rights and permissions
About this article
Cite this article
Omapatrilat: increased risk of angioneurotic oedema. Inpharma Wkly. 1331, 21 (2002). https://doi.org/10.2165/00128413-200213310-00052
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213310-00052